Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-negative Metastatic Breast Cancer
Interventions: BIOLOGICAL: Chemotherapy monitoring by circulating tumor DNA analysis
Sponsor: Institut Curie